「Correlates of Protection」の版間の差分

提供: Vaccipedia | Resources for Vaccines, Tropical medicine and Travel medicine
ナビゲーションに移動 検索に移動
12行目: 12行目:
 
|An immune response surrogating mCoP and easily measured
 
|An immune response surrogating mCoP and easily measured
 
|}
 
|}
 +
 +
===Identifying method of CoP (mCoP)===
 +
*Theoretically
 +
**To measure immune responses '''at the time of exposure to the infection''' and compare them between those who get infection and not
 +
*Practically
 +
**To measure immune responses '''after the vaccination''' and compare them between those who get infection and not
 +
***usually done in vaccine clinical trial phase 3
 +
**To measure immune responses '''at the time of challenging exposure of vaccinated volunteers'''
 +
***would be ethically approved only for milder and/or treatable infections such as seasonal influenza, cholera, dengue or cytomegalovirus
 +
**To extrapolate vaccinated animal challenge model
 +
**To extrapolate protective level of dosing of passive immunization (antibody treatment)

2022年10月22日 (土) 13:28時点における版

Correlates of Protection

Definitions of terms
Correlates of Protection (CoP) An immune response statistically correlated with protection
Mechanistic CoP (mCoP) An immune response responsible for protection
Non-mechanistic CoP (nCoP) An immune response surrogating mCoP and easily measured

Identifying method of CoP (mCoP)

  • Theoretically
    • To measure immune responses at the time of exposure to the infection and compare them between those who get infection and not
  • Practically
    • To measure immune responses after the vaccination and compare them between those who get infection and not
      • usually done in vaccine clinical trial phase 3
    • To measure immune responses at the time of challenging exposure of vaccinated volunteers
      • would be ethically approved only for milder and/or treatable infections such as seasonal influenza, cholera, dengue or cytomegalovirus
    • To extrapolate vaccinated animal challenge model
    • To extrapolate protective level of dosing of passive immunization (antibody treatment)